You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ATR inhibitor

Showing 1 - 25 of 7,429
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors, Hematological Malignancies Trial (ATG-018)

Not yet recruiting
  • Advanced Solid Tumors
  • Hematological Malignancies
  • (no location specified)
Apr 14, 2022

Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

Recruiting
  • Advanced Fallopian Tube Carcinoma
  • +21 more
  • Biopsy
  • +2 more
  • Bethesda, Maryland
  • +2 more
Jan 25, 2023

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Solid Tumor Trial

Withdrawn
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • (no location specified)
May 24, 2022

Prostate Cancer Trial in Ann Arbor, Detroit, Charlottesville (Olaparib, AZD6738)

Active, not recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +2 more
Jan 9, 2023

NSCLC Trial in Pittsburgh (M1774, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center
May 22, 2023

Tumors Trial in Bethesda, Boston, Houston (Veliparib + VX-970 + Cisplatin)

Completed
Has Results
  • Neoplasms
  • Veliparib + VX-970 + Cisplatin
  • Bethesda, Maryland
  • +2 more
Jan 14, 2022

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • (no location specified)
Jan 14, 2023

Oesophageal Adenocarcinoma, Squamous Cell Carcinoma, Solid Tumor Trial in United Kingdom (M6620, Cisplatin, Capecitabine)

Completed
  • Oesophageal Adenocarcinoma
  • +2 more
  • Cardiff, United Kingdom
  • +4 more
Apr 27, 2022

Advanced Solid Tumor, Recurrent Endometrial Cancer, Metastatic Cancer Trial (ART0380)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • (no location specified)
Apr 5, 2023

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

Healthy Trial in Neu-Ulm (ATR-002, Placebo, Repaglinide)

Recruiting
  • Healthy
  • Neu-Ulm, Germany
    Atriva study site
Sep 22, 2022

Advanced Solid Tumor Trial in Worldwide (RP-3500, Talazoparib, Gemcitabine Injection [Gemzar])

Recruiting
  • Advanced Solid Tumor
  • Chicago, Illinois
  • +12 more
Nov 18, 2022

High Grade Serous Carcinoma Trial in Baltimore, Boston, Philadelphia (Olaparib Pill, AZD6738)

Recruiting
  • High Grade Serous Carcinoma
  • Baltimore, Maryland
  • +2 more
Mar 4, 2022

Advanced Solid Tumor, Adult Trial in United States (RP-3500)

Recruiting
  • Advanced Solid Tumor, Adult
  • New Haven, Connecticut
  • +6 more
Mar 9, 2022

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Kraków, Poland
  • +10 more
Dec 2, 2022

Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell

Not yet recruiting
  • Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +5 more
  • (no location specified)
Jul 13, 2023

Advanced Solid Tumor, Breast Cancer Trial (Niraparib, M4344)

Withdrawn
  • Advanced Solid Tumor
  • Breast Cancer
  • (no location specified)
Jun 24, 2021

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,

Recruiting
  • Advanced Bile Duct Carcinoma
  • +33 more
  • Sacramento, California
  • +6 more
Aug 11, 2022

Epidermal Growth Factor, Papulopustular Rosacea Trial in Irving (ATR-04, Placebo)

Suspended
  • Epidermal Growth Factor
  • Papulopustular Rosacea
  • Irving, Texas
    RCTS, Inc.
Jun 2, 2021

Cancer Trial in Cambridge (AZD6738, Gemcitabine)

Recruiting
  • Cancer
  • Cambridge, England, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Jun 3, 2021

Gynaecological Cancers Trial in London (AZD6738, Olaparib)

Recruiting
  • Gynaecological Cancers
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Sep 2, 2020